Sickle Cell disease is a genetic blood disorder affecting approximately 100,000 Americans. Patients need therapy to cure, delay disease progression, or mitigate disease-related effects. In the last 5 years the number of therapies to delay the progression of sickle cell disease has tripled. Do not miss the opportunity to hear from experts in the field on what these new therapeutics mean for the management of sickle cell disease.
Summarize the available therapies for the treatment of sickle cell anemia.
Determine the ideal candidate for the new therapeutic options available for the prevention of sickle cell disease complications.
Given a patient case, develop an appropriate treatment plan for the management of vaso-occlusive crises.